Stockreport

Insmed eyes Arikayce label expansion on Phase IIIb lung disease success [Yahoo! Finance]

Insmed Incorporated  (INSM) 
Last insmed incorporated earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF In the ENCORE study (NCT04677569), the antibiotic plus a multidrug combination of azithromycin and ethambutol significantly improved the baseline change in respiratory [Read more]